top of page


How Budget Impact Analysis Supports Drug Pricing and Market Access
Introduction When a new therapy is preparing to enter the market, policymakers and payers face two critical questions: Is the drug good value for money? and Can we afford it? Cost-effectiveness analysis (CEA) addresses the first question, but budget impact analysis (BIA) is designed to answer the second. In modern market access strategies, BIA has become an indispensable complement to CEA, offering a practical view of the financial consequences of adopting a new medicine with
Fay
1 day ago4 min read


AI in Drug Safety: How New Technology Helps the FDA Spot Problems Earlier and What That Means for Patients
By Vanessa Muller, PharmD Most people don’t think about the technology behind medication safety. You pick up a prescription, read the instructions, and trust that if something important changes, your doctor will hear about it. But the amount of safety information that experts handle today is far greater than it used to be. Every year, the U.S. Food and Drug Administration (FDA) reviews millions of safety reports, research findings, electronic health-record patterns, and globa
Vanessa Muller
2 days ago5 min read


The Hidden Power of Micro-Moments: Health in 5 Minutes
Introduction Health doesn’t always have to mean changing everything about your life. Sometimes, it’s about winning back a few minutes—like those spent waiting for your coffee to brew. What if you used these moments for yourself? Recent research shows that micro-moments—short, intentional actions like stretching, mindful breathing, or simply being grateful—can transform mood, lower stress, and boost heart health, all in less than five minutes. Micro-Moments and Everyday Healt
Sonia Dufour
2 days ago2 min read
bottom of page



